NORTH ANDOVER, Mass.--(BUSINESS WIRE)-- <\/p>\n
MindChild Medical, Inc., today announced results of a recently sponsored national survey of hospital administrators and obstetricians (NSFM3) focused on trends in fetal monitoring. Recent fetal monitoring literature suggests that of the 4.3 million US live births recorded in 20074, 1.4 million, or over 30%5, occurred where the mother had a BMI (Body Mass Index) exceeding 30kg\/m2 considered the effective limit for existing non-invasive fetal monitoring technology6. <\/p>\n
Key findings of the NSFM Survey included: <\/p>\n
Michael G. Ross, MD, MPH7, Professor, Department of Obstetrics and Gynecology at the Geffen School of Medicine at UCLA commented, Noninvasive FHR monitoring may result in inadvertent monitoring of maternal heart rate, which can be mistaken for fetal heart rate, particularly in obese patients. The increase in maternal BMI seen nationally over the recent past is a troubling trend that has significant negative implications for the accuracy of existing non-invasive FHR monitoring technologies. The use of non-invasive surface electrodes can potentially improve in the monitoring of fetal heart rate and aid in prevention of adverse outcomes associated with mistaken maternal heart rate monitoring. <\/p>\n
Previous Announcements <\/p>\n
On February 22, 2012, MindChild reported formation of a Clinical Advisory Board for the MERIDIAN Line of Non-Invasive Fetal Heart Rate Monitors <\/p>\n
On February 6, 2012, MindChild reported filing of a 510(k) Pre-Marketing Notification Application with the US Food and Drug Administration for the MERIDIAN Line of Non-Invasive Fetal Heart Rate Monitors <\/p>\n
About the MERIDIAN Non-Invasive Fetal Heart Rate Monitor <\/p>\n
MERIDIAN is a fetal monitor that non-invasively measures and displays Fetal Heart Rate (FHR). MERIDIAN acquires and displays the FHR tracing from abdominal surface electrodes that detect the fetal ECG signal (fECG). MERIDIAN may also be used to measure and display FHR using a Fetal Scalp Electrode (FSE). MERIDIAN is designed for women who are at term (> 36 completed weeks), in labor, with singleton pregnancies, using surface electrodes on the maternal abdomen. MERIDIAN is intended for use by healthcare professionals in a clinical setting. <\/p>\n
About the Fetal Heart Monitoring Market <\/p>\n<\/p>\n
See the original post:<\/p>\n
MindChild Medical, Inc., Announces Results of National Fetal Monitoring Market Survey<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" NORTH ANDOVER, Mass.--(BUSINESS WIRE)-- MindChild Medical, Inc., today announced results of a recently sponsored national survey of hospital administrators and obstetricians (NSFM3) focused on trends in fetal monitoring. Recent fetal monitoring literature suggests that of the 4.3 million US live births recorded in 20074, 1.4 million, or over 30%5, occurred where the mother had a BMI (Body Mass Index) exceeding 30kg\/m2 considered the effective limit for existing non-invasive fetal monitoring technology6. Key findings of the NSFM Survey included: Michael G Continue reading